Navigation Links
Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/2/2010

SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 12th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2010 at 10:00 a.m. EST (7:00 a.m. PST).  The conference is being held at the Waldorf-Astoria Hotel in New York.  Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical development programs, ANA598 and ANA773.

Additionally, Dr. Worland will participate as a panelist on the BIO CEO & Investor Conference HCV Panel on Tuesday, February 9, 2010 at 12:00 p.m. EST (9:00 a.m. PST).

The corporate presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at www.anadyspharma.com.  Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through February 23, 2010.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for th
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
2. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
3. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
5. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
6. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
7. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
8. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
9. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
10. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
11. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)... 15, 2014 BreedIT Corp (OTC: BRDT), ... distributor of highly sophisticated agro-breeding solutions for plant breeders ... the Company,s board of directors appointed chemistry and pharmaceutical ... new member of the board. From 1975 ...
(Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was promoted from ... has overseen the company,s four facilities in Massachusetts ... Mr. King joined Tegra Medical in 2012 with 20+ years ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... 11, 2011 GSA Applications is pleased to announce ... a GSA Schedule 65IIA contract and are now certified ... Federal officials appreciate GSA Schedules as a means of ... qualified by the General Services Administration (GSA). Darah Medical ...
... 11, 2011 Reportlinker.com announces ... report is available in its ... Defibrillators - Global Opportunity Assessment, ... to 2016 ...
Cached Medicine Technology:Darah Medical Awarded GSA Schedule, Launches Online Store 2External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 2External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 3External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 4External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 5External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 6External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 7External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 8External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 9External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 10
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2
... 14, 2011) Research has shown that playing a musical ... but playing a used instrument also can pose a potentially ... were found to be heavily contaminated with a variety of ... to serious infectious and allergic diseases, according to a study ...
... opportunity for over 6,000 clinicians and scientists from ... perspectives and treatments for liver diseases from principal ... and multi-disciplinary scientific programme covering groundbreaking information and ... EASL will hold an international press conference and ...
... , MONDAY, March 14 (HealthDay News) -- Watching ... much fun for those who bet on the games, one ... online betting sites and spoiler message boards seems to suggest ... the case, according to Stephen M. Nowlis, a marketing professor ...
... joyous time however some women experience overwhelming ,baby blues, before ... can result in premature birth, or low birth weight, and ... New research published in BioMed Central,s open access journal ... their husband or partner is the strongest predictor of maternal ...
... cancer tumors take numerous paths to resist the targeted ... crossroads may restore a tumor,s vulnerability to treatment, scientists ... report on line at Nature Medicine . ... resistant tumors by cutting off at least five different ...
... Reporter , FRIDAY, March 11 (HealthDay News) -- Forget ... disappointment in romantic relationships. Those who are unrealistically ... marriage than the realists, new research contends. The ... satisfaction that strikes marriages over time, said study author ...
Cached Medicine News:Health News:Is your child's hobby making him sick? 2Health News:International Liver Congress 2011 2Health News:Combination overcomes breast cancer resistance to herceptin 2Health News:Combination overcomes breast cancer resistance to herceptin 3Health News:Think You Have a Perfect Partner? That's a Good Sign 2Health News:Think You Have a Perfect Partner? That's a Good Sign 3
Malaria device / strip (2 line, P.f.-HRP2 Test)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
BioSign® Malaria - Rapid Malaria Antigen Test...
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples....
Medicine Products: